Consolidated Balance Sheets (Unaudited) (Parenthetical) - USD ($) $ in Millions	Jun. 30, 2024	Dec. 31, 2023
Assets
Amortized cost of fixed maturity securities valuation allowances	$ 121	$ 184
Amortized Cost	303,191	300,555
Mortgage loans valuation allowances	806	721
Real estate and real estate joint ventures - FVO	13,517	13,332
Other Invested Assets - Leveraged and Direct Financing Leases	1,863	1,993
Other invested assets, at estimated fair value (2)	18,131	18,202
Liabilities
Long-term debt	$ 14,809	$ 15,548
MetLife, Inc.’s stockholders’ equity:
Preferred stock, par value	$ 0.01	$ 0.01
Preferred stock, Liquidation Preference, Value	$ 3,905	$ 3,905
Common stock, par value	$ 0.01	$ 0.01
Common stock, shares authorized	3,000,000,000	3,000,000,000
Common stock, shares issued	1,193,636,489	1,191,823,651
Common stock, shares outstanding	703,760,956	730,821,111
Treasury stock, shares	489,875,533	461,002,540
Short-term Debt	$ 390	$ 119
Real Estate Held-for-sale	34	0
Residential mortgage loans - FVO
Assets
Real estate and real estate joint ventures - FVO	321	317
Variable interest entities
Assets
Real estate and real estate joint ventures - FVO	210	0
Other invested assets, at estimated fair value (2)	429	333
MetLife, Inc.’s stockholders’ equity:
Short-term Debt	$ 113	$ 0